The Rheumatologist
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
  • Technology
    • Electronic Health Records
    • Apps
    • Information Technology
  • Resources
    • Issue Archives
    • Events
    • Multimedia
      • Audio
      • Video
    • From the College
    • American College of Rheumatology
    • Rheumatology Research Foundation
    • Arthritis & Rheumatology
    • Arthritis Care & Research
    • Treatment Guidelines
    • Research Reviews
    • Annual Meeting
      • Abstracts
      • Meeting Reports
    • Rheumatology Image Bank
    • ACR ExamRheum
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Psoriasis

Articles tagged with "Psoriasis"

Tildrakizumab Promising for Psoriasis in Patients with PsA

December 2, 2019 • By Michele B. Kaufman, PharmD, BCGP

Scottish Medicines Consortium Recommends Risankizumab; Plus Real-World Data on Secukinumab

November 4, 2019 • By Michele B. Kaufman, PharmD, BCGP

Japan Approves Risankizumab for Psoriasis & Psoriatic Arthritis

April 15, 2019 • By Michele B. Kaufman, PharmD, BCGP

For Psoriasis, Ustekinumab & TNF Inhibitors Show Similar Cardiac Safety

April 9, 2019 • By David Douglas

Patients with Psoriatic Arthritis at Increased Risk for Type 2 Diabetes

December 3, 2018 • By Lara C. Pullen, PhD

Piclidenoson in Trials for Psoriasis & RA; Plus Duzallo Approved in Europe

September 18, 2018 • By Michele B. Kaufman, PharmD, BCGP

Adalimumab Appears Safe for Treating Pediatric Patients with Autoimmune Disease

August 8, 2018 • By Reuters Staff

Dietary Recommendations for Psoriasis Patients

August 2, 2018 • By Lara C. Pullen, PhD

Certolizumab Pegol Receives FDA Approval for Plaque Psoriasis

June 18, 2018 • By Michele B. Kaufman, PharmD, BCGP

FDA Updates Ixekizumab Label to Include Genital Area Psoriasis

June 6, 2018 • By Michele B. Kaufman, PharmD, BCGP

  • 1
  • 2
  • 3
  • …
  • 7
  • Next Page »

Simple Tasks

Learn more about the ACR’s public awareness campaign and how you can get involved. Help increase visibility of rheumatic diseases and decrease the number of people left untreated.

Visit the Simple Tasks site »

ACR/ARP Annual Meeting

Don’t miss rheumatology’s premier scientific meeting for anyone involved in research or the delivery of rheumatologic care or services.

Visit the ACR Annual Meeting site »

Rheumatology Research Foundation

The Foundation is the largest private funding source for rheumatology research and training in the U.S.

Learn more »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2019 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)

This site uses cookies: Find out more.